Eos: a novel member of the Ikaros gene family expressed predominantly in the developing nervous system  by Honma, Yutaka et al.
Eos: a novel member of the Ikaros gene family expressed predominantly
in the developing nervous system
Yutaka Honmaa, Hidenori Kiyosawaa, Tetsuji Moria, Atsushi Oguria, Takuya Nikaidoa,
Ken-ya Kanazawaa, Michiko Tojoa, Junko Takedaa, Yoshihiro Tannoa, Sachihiko Yokoyaa,
Isao Kawabatab, Hisami Ikedab, Akio Wanakaa;*
aDepartment of Cell Science, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima City,
Fukushima 960-1295, Japan
bDepartment of Laboratory Medicine, Asahikawa Medical College, Nisikagura 4-5, Asahikawa 078-8307, Japan
Received 1 December 1998; received in revised form 8 February 1999; accepted 17 February 1999
Abstract We identified a novel member of the Ikaros gene
family, which has critical roles in the development of lymphoid
lineages. This gene, which we named Eos, was expressed
predominantly in the developing central and peripheral nervous
system. Eos protein could interact with itself and Ikaros protein
through its C-terminal portion in the yeast two hybrid assay.
These findings suggested that Eos may have important roles in
neural development similarly to the Ikaros family in the
development of hemolymphoid tissue.
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1. Introduction
The Ikaros gene, which encodes a hemopoietic-speci¢c zinc
¢nger protein, is one of the central regulators of lymphocyte
di¡erentiation [1]. Loss of function experiments suggested that
it is required at the earliest stage of B-cell and T-cell speci¢-
cation during fetal development and that lymphoid lineages
rely on Ikaros at distinct phases of their development in adults
[2,3]. In addition, Ikaros null thymocytes proliferate aggres-
sively in response to T-cell receptor signalling, suggesting that
Ikaros is a tumor suppressor gene for the T-cell lineage [4].
Ikaros isoforms unable to bind DNA exhibited dominant neg-
ative activity in lymphocyte development, suggesting that
Ikaros works in concert with other factors [4,5]. Indeed, two
structurally related genes, Aiolos and Helios, have been iden-
ti¢ed and shown to have lymphoid-restricted patterns of ex-
pression [6^8]. These factors were shown to form a complex
regulatory protein network that controls cell fate decisions
and regulates homeostasis in the hemolymphoid system (re-
viewed in [9,10]). The C-terminal Zn ¢nger domain is indis-
pensable for these protein-protein interactions [11].
We have been screening genes that are speci¢cally up-regu-
lated in the long term cultured mouse astrocytes (in vitro
gliosis model) by di¡erential display in order to identify glio-
sis-related genes. During the course of this screening, we iden-
ti¢ed a cDNA fragment with a signi¢cant sequence homology
to mouse Ikaros family members. In the present study, we
characterized the structure and the expression pattern of this
novel member of the Ikaros family, which we named Eos
(Greek word for rising sun).
2. Materials and methods
Astrocyte-enriched cultures were established from newborn mouse
brains (ICR strain) as described previously [12]. The periods for short
and long term cultures were 2 and 12 weeks, respectively. Total RNA
was isolated by the acid guanidinium isothiocyanate/phenol-chloro-
form method from both long and short term cultured astrocytes.
Di¡erential display was carried out essentially as described previously
[13]. We used about 100 di¡erent arbitrary primers (17-mers) for
screening. After separation by 5% polyacrylamide gel electrophoresis,
cDNA bands of interest were cut out from the gels, re-ampli¢ed with
the same primers and then cloned into the pGEM-T Easy vector
(Promega). DNA sequencing of the cloned fragments was performed
using a Taq dye terminator cycle sequencing kit (Perkin-Elmer).
In order to obtain a full length cDNA, the cDNA fragment iden-
ti¢ed by di¡erential display was random prime-labelled and used to
screen 1U106 plaques of a mouse whole brain Vgt10 cDNA library
(Clontech) and a neonatal mouse brain VZAPIIcDNA library (Stra-
tagene). Standard phage screening techniques were employed. For
Northern analysis, total RNAs (20 Wg) from the brain and liver of
the developing (embryonic day 15 (E15), E18, postnatal day 0 (P0), P7
and adult) mice and from the spleen, kidney, lung and thymus of P0,
P7 and adult mice were denatured with glyoxal and fractionated by
electrophoresis through 1.0% agarose/formamide gels and transferred
onto Zeta-Probe membranes (Bio-Rad). All other procedures were as
described previously [13]. In situ hybridization using digoxigenin-la-
belled cRNA probes was performed as described previously [14]. Di-
goxigenin-labelled probes (antisense and sense probes) were made by
in vitro transcription using cDNAs subcloned into the pGEM-T Easy
vector as templates in the presence of digoxigenin-labelled dUTP.
We performed the following yeast two hybrid assay using a Match-
maker kit (Clontech Laboratories) according to the manufacturer’s
protocol. Full length mouse Eos as well as cDNA fragments encoding
the N-terminal half (Eos-N) and C-terminal half of Eos (Eos-C) (see
Fig. 3) were cloned in frame to the GAL4 DNA binding domain in
the bait pGBT9 plasmid using standard molecular techniques. Full
length Eos and human Ikaros genes were also cloned in frame to
the GAL4 transcription activation domain of the prey vector
pGAD424. Bait and prey vectors were transformed into the SFY526
yeast strain and the transformed yeast was grown on plates without
tryptophan and leucine to select double transformants. The selected
colonies were then subjected to a L-galactosidase assay. The ability of
Eos and Eos fragments expressed in the bait vectors to activate lacZ
gene expression was determined by the extent of color reaction on
¢lters soaked with X-gal solution.
3. Results
We isolated a cDNA fragment (about 1.0 kb in size) during
di¡erential display screening of genes that were up-regulated
in long term cultured astrocytes. Its partial sequence was de-
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termined and a database search revealed a signi¢cant homol-
ogy to Ikaros, a Zn ¢nger transcription factor (data not
shown). By a RNase protection assay, the gene expression
was con¢rmed to be up-regulated in long term cultured astro-
cytes (data not shown). To obtain the full length cDNA of
this gene, we screened a cDNA library with the cDNA frag-
ment identi¢ed by di¡erential display and isolated two over-
lapping cDNAs. Their nucleotide sequences were determined
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Fig. 1. Structure of the Eos gene product. Alignment of the predicted amino acid sequence of Eos with the sequences of Helios, Aiolos and
Ikaros is shown. Amino acids outlined in black represent identical residues. Cysteine and histidine residues comprising the C2H2 type Zn ¢nger
domain are marked with closed triangles, except for the atypical cysteine residue in the fourth ¢nger (indicated by an open triangle) and the
histidine residues in the sixth ¢nger (indicated by open squares).
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and combined to yield a 2.8 kb cDNA that contained an open
reading frame encoding a protein homologous to the Ikaros
family (Ikaros, Aiolos and Helios, Fig. 1). We named this
gene Eos to follow the naming of the family members. The
Eos protein consisted of 533 amino acids and overall sequence
similarities were as follows: Eos-Helios, 83.3%; Eos-Aiolos,
82.4%; Eos-Ikaros,72%. The Eos protein had several structur-
al motifs common to the Ikaros family members, namely four
Zn ¢nger motifs in its N-terminal side, transcriptional activa-
tion domain and two Zn ¢nger motifs implicated in homo- or
hetero-dimerization with the family members. These domains
had stronger homologies with corresponding domains of
known members (Fig. 1) than with the remaining regions.
The unusual cysteine residue in the fourth Zn ¢nger (C2HC
type) common to the Ikaros family members was also con-
served in the Eos protein (Fig. 1, indicated by an open trian-
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gle). The sixth Zn ¢nger motif (C2H2 type) also showed a
characteristic structure in that ¢ve amino acids were inserted
between histidine residues (Fig. 1, indicated by open squares),
reminiscent of the zinc ¢nger domain of the Drosophila hunch-
back protein [15].
We examined the tissue distribution of Eos mRNA by
Northern blotting analysis. Eos transcript was detected pre-
dominantly in the brain as a band of 4.8 kb (Fig. 2a). The
intensity of the signal was strong in the E15 and E18 brain
and gradually decreased as the postnatal development pro-
ceeded (Fig. 2a, upper panel). No signals were detected in
the liver, kidney, lung, thymus or spleen during all develop-
mental stages we examined (Fig. 2a, lower panel for the liver,
data not shown for the kidney, lung, thymus and spleen). The
expression pattern was in marked contrast to those of the
known Ikaros family members. Ikaros mRNA was primarily
observed in the hemopoietic tissues in the embryo and later in
the lymphoid tissues [1]. Aiolos and Helios mRNAs were also
mainly expressed in the lymphoid lineage [6,7]. By in situ
hybridization histochemistry, we detected a signi¢cant signal
for Eos mRNA in the embryonic nervous system from the
earliest age we examined (E11, data not shown). Its distribu-
tion was almost ubiquitous in the central (Fig. 2b and d) and
peripheral nervous systems (Fig. 2f and g). Eos mRNA was
weakly detected in the embryonic thymus (Fig. 2b, arrow),
suggesting that Eos and Ikaros family members may be co-
expressed in the thymus. There is, however, another possibil-
ity that Eos probe may have cross-hybridized with known
members of the Ikaros family. Consistent with the Northern
analysis, Eos mRNA expression decreased gradually after
birth and at P7, only weak signals were observed in the pyr-
amidal and granule cell layers of the hippocampus (Fig. 2e).
In the adult, Eos mRNA was slightly observed in the hippo-
campus by in situ hybridization (data not shown).
Ikaros family members have been shown to interact with
themselves and with other members through the C-terminal
Zn ¢nger domain [11]. As the overall structure of the pre-
dicted Eos protein was very similar to those of the known
Ikaros family members, Eos protein was suspected to dimerize
with itself and possibly with Ikaros family members. To test
these possibilities, we employed the yeast two hybrid assay. As
shown in Fig. 3, full length Eos protein (Eos-F) interacted
with full length Ikaros protein (a) in yeast. However, Eos-N
did not show any sign of interaction with Ikaros protein (b),
while Eos-C did. These ¢ndings suggested that the Eos protein
dimerizes through the C-terminal Zn ¢nger domain with
Ikaros protein, consistent with results of the previous studies
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Fig. 2. Tissue expression of Eos mRNA. (a) Northern analysis of Eos mRNA expression in the developing brain and liver. 1: Embryonic day
15 (E15), 2: E18, 3: postnatal day 0 (P0), 4: P7, 5: adult. The upper panel showed a band of 4.8 kb in the developing brain. Note that the
embryonic brain exhibited a strong signal for Eos mRNA and the intensity gradually decreased as the mouse grew. The lower panel showed
that Eos mRNA expression was under the detectable level in the developing liver at all stages. In both panels, 18s ribosomal RNA bands
stained with ethidium bromide showed that equal amounts of RNA were loaded in each lane. We examined the developing lung, kidney, thy-
mus and spleen (P0^adult) similarly, but did not detect any signal for Eos mRNA (data not shown). (b) In situ hybridization analyses of Eos
mRNA expression in the E18 embryo. Note that the brain and spinal cord were labelled intensely and ubiquitously by the Eos probe. The thy-
mus was also weakly labelled (arrow). The gut (asterisk) exhibited staining but it was considered to be non-speci¢c because similar staining was
observed in the sense control (asterisk in c). (c) Sense control for in situ hybridization. An adjacent section to (b) was hybridized with the sense
probe. Bars in b and c are 2 mm. (d) Eos mRNA expression in the E14 brain. The brain was labelled ubiquitously and the cortical plate (ar-
rowheads) in which relatively di¡erentiated neurons are localized was also intensely stained. Bar = 500 Wm. (e) Eos mRNA expression in the P7
hippocampus. At this stage, the level of Eos mRNA expression was decreased and only the hippocampal pyramidal neurons (arrows) and gran-
ule neurons (arrowheads) were weakly positive. Bar = 250 Wm. (f) Eos mRNA expression in the E14 dorsal root ganglion. The arrow indicates
the dorsal root ganglion. Neurons were labelled intensely. The spinal cord was also positive (arrowheads). Bar = 300 Wm. (g) Eos mRNA ex-
pression in the E14 trigeminal ganglion. The arrow indicates the trigeminal ganglion stained ubiquitously. Bar = 300 Wm.
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Fig. 3. Yeast two hybrid analyses of Eos and Ikaros protein interac-
tions. The upper panel shows a schematic representation of the
Ikaros family protein. The Zinc ¢nger motif is depicted as a hatched
box and the shaded box indicates the transcriptional activation do-
main. Relative positions of the mouse Eos-N and Eos-C are shown.
The lower panel shows the results of yeast two hybrid analyses. a:
Eos full length/Ikaros full length, b: Eos-N/Ikaros full length, c:
Eos-C/Ikaros full length, d: Eos full length/Eos full length, e: Eos-
N/Eos full length, f: Eos-C/Eos full length, g: positive control for
protein-protein interaction. Plasmids (pVA3 and pTD1) that are
known to interact in the yeast two hybrid system were transformed
and a color reaction was performed.
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(reviewed in [9,10]). Eos-F interacted with itself (d) and Eos-C
(f) with a comparable color development. The combination of
Eos-F and Eos-N showed a color reaction with less intensity
but above background, suggesting that an interaction may
take place (e). This interaction may be speci¢c to the case
of Eos-Eos self interaction as Eos-F did not appear to interact
with Ikaros-N (b).
4. Discussion
The Ikaros family has been implicated in hemolymphoid
development. Critical functions of this family in the lymphoid
tissues were suggested by the loss of function experiments
[2,16]. In the present study, we identi¢ed a novel member of
this family, Eos, which is primarily expressed in the develop-
ing nervous system. By analogy, it is likely that Eos has im-
portant roles in the development of both central and periph-
eral nervous systems. Of the known members of this family,
Ikaros mRNA expression was detected in the restricted region
of the basal forebrain and midbrain of the embryo [1] and
Helios mRNA was localized to the germinal zone of the em-
bryonic brain [8]. It is possible that Ikaros and Helios exert
their functions in these regions by dimerization with Eos.
Judging from the distribution pattern, Eos probably has
more essential functions in neural development than the other
known family members. A recent report suggested that the
neuronal enkephalin gene may be under control of Ikaros-
like transcription factor(s) [17]. Eos may be involved in such
determination of transmitter phenotype of the developing
nervous system. Functional aspects of the Eos protein are
now under investigation.
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